NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-021 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide support for institutional research training programs in Alzheimers Disease/Alzheimers Disease-Related Dementias (AD/ADRD). These institutional research training programs should produce well-trained neuroscientists who leave the program with the research skills and scientific knowledge to make a significant contribution to research on AD/ADRD cognitive impairment and dementia. Programs should be designed to enhance the breadth and depth of training across the spectrum AD/ADRD research areas (e.g. AD, Vascular...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 27, 2021 Category: Research Source Type: funding
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-22-017 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to have an open competition to support a Coordinating Center for the next phase of the NINDS small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers consortium. The original consortium was established under RFA-NS-16-019 and RFA-NS-16-020. The goal of the next phase, under this FOA (Coordinating Center) and RFA-NS-20-005 (sites), is to complete clinical validation of biomarkers initially developed during the first 5-year funding cycle of this prog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2021 Category: Research Source Type: funding
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)
Funding Opportunity RFA-NS-22-009 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications that address the unmet need to detect cognitive impairment, including dementia, in large and diverse populations seen in primary care across the United States, including in health disparities populations, when a patient, relative, or care provider indicates concern. Proposed clinical paradigms should utilize tools that are simple to use, standardized, and ideally take five minutes or less to administer in a primary care clinical setting. (Source: NIH Funding ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 8, 2021 Category: Research Source Type: funding
Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-026 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit studies that will advance the mechanistic understanding of small vessel vascular contributions to cognitive impairment and dementia (VCID) through the development of new technologies and innovative methods that enable the imaging and/or functional assessment of the small blood and lymphatic vessels and perivascular spaces of the brain. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 19, 2021 Category: Research Source Type: funding
Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required)
Funding Opportunity PAR-21-307 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimers disease (AD) and Alzheimers disease-related dementias (ADRD) and of those providing their care. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 11, 2021 Category: Research Source Type: funding
Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required)
Funding Opportunity PAR-21-308 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement(FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimers disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 11, 2021 Category: Research Source Type: funding
Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-024 from the NIH Guide for Grants and Contracts. This FOA invites investigation of biological and clinical measures of TBI-related progressive neurodegeneration and neurocognitive decline associated with increased risk for dementia and /or traumatic encephalopathy syndrome (TES) (clinicopathologic diagnostic counterpart to the neuropathological diagnosis of Chronic Traumatic Encephalopathy (CTE)). Investigations should be based on existing, well-characterized populations of patients with a history of TBI that are enriched for increased risk of cognitive impairment or dementia and can continue ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 10, 2021 Category: Research Source Type: funding
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-22-010 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support short courses geared towards advancing selected priority topic areas identified by the National Institute on Aging in order to advance behavioral and social science research on Alzheimer's disease and its related dementias (AD/ADRD). This FOA targets the following three priority research areas: 1) cross-national dementia research using harmonized data on cognitive function; 2) behavioral economic approaches to improve AD/ADRD health care delivery at the organizational level...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 23, 2021 Category: Research Source Type: funding
Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations
Notice NOT-NS-21-037 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2021 Category: Research Source Type: funding
The Kevin and Avonte Program: Reducing Injury and Death of Missing Individuals with Dementia and Developmental Disabilities
Grant program designed to reduce the number of deaths and injuries of individuals with forms of dementia or developmental disabilities who, due to their condition, wander from safe environments. Funding will be used by law enforcement and other public safety agencies to implement locative technologies that track missing individuals, and to partner with nonprofit organizations to develop and operate programs to prevent wandering, increase safety, and facilitate rescues. Projects in rural communities are a priority. Geographic coverage: Nationwide -- Bureau of Justice Assistance, U.S. Department of Justice (Source: Funding o...
Source: Funding opportunities via the Rural Health Information Hub - December 22, 2020 Category: American Health Source Type: funding
Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed)
Funding Opportunity RFA-NS-21-005 from the NIH Guide for Grants and Contracts. T?o invite applications to an open competition to be one of up to 7 supported sites in the next phase of the NINDS small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers consortium. The original consortium, established under RFA-NS-16-019 and RFA-NS-16-020, pursued initial stages of multi-site validation of 11 candidate imaging-based and fluid-based biomarkers. The primary objective of the next 5 years is to carry out comprehensive multi-site clinical validation of up to six of these 11 biomarkers to be sel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 23, 2020 Category: Research Source Type: funding
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-21-004 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to have an open competition to support a Coordinating Center for the next phase of the NINDS small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers consortium. The original consortium was established under RFA-NS-16-019 and RFA-NS-16-020. The goal of the next phase, under RFA-NS-20-004 (Coordinating Center) and RFA-NS-20-005 (sites), is to complete clinical validation of biomarkers initially developed during the first 5-year funding cycle of this...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 23, 2020 Category: Research Source Type: funding
Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required)
Funding Opportunity RFA-NS-21-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications from experienced investigators seeking to conduct exploratory clinical trials designed to test new treatments for patients with Lewy Body Dementia (LBD). Applicants may propose to conduct either Phase I or Phase II clinical trials depending on the developmental stage of the potential therapeutic, but all trials must include patients with LBD. Proposed therapies may include novel medications or devices, or existing treatments that are potentially beneficial but not currently approved f...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 28, 2020 Category: Research Source Type: funding
Center without Walls for Molecular Mechanisms of Neurodegeneration in Frontotemporal Degeneration (FTD) (U54 Clinical Trial not Allowed)
Funding Opportunity RFA-NS-21-003 from the NIH Guide for Grants and Contracts. The goal of the Frontotemporal Dementia (FTD) Centers Without Walls (CWOW) is to improve our understanding of the mechanisms underlying neurodegeneration in FTD through multi-disciplinary, team-based science to address a specific challenge or challenges in the field that could not be achieved through individual research projects. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2020 Category: Research Source Type: funding
Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-21-007 from the NIH Guide for Grants and Contracts. Accumulation of abnormal proteins such as alpha-synuclein or tau in the brains of patients with dementia tends to occur in specific brain structures (cells/circuits/regions), resulting in the unique clinical presentations that are characteristic of the different types of dementia. This funding opportunity announcement invites applications that seek to identify mechanisms responsible for this selective regional vulnerability to abnormal protein deposition in the brains of patients with Lewy Body Dementia or Frontotemporal Dementia. (Source: NI...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 13, 2020 Category: Research Source Type: funding
